These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7911458)

  • 1. The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator.
    Huet G; Zerimech F; Dieu MC; Hemon B; Grard G; Balduyck M; Janin A; Lafyatis R; Degand P
    Int J Cancer; 1994 Jun; 57(6):875-82. PubMed ID: 7911458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cathepsin D dependent on the phenotype of colon carcinoma cells.
    Hennebicq Reig S; Kim I; Janin A; Grard G; Hémon B; Moreau O; Porchet N; Aubert JP; Degand P; Huet G
    Int J Cancer; 1996 Nov; 68(4):479-84. PubMed ID: 8945619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line.
    De Stefanis D; Démoz M; Dragonetti A; Houri JJ; Ogier-Denis E; Codogno P; Baccino FM; Isidoro C
    Cell Tissue Res; 1997 Jul; 289(1):109-17. PubMed ID: 9182605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protease activities in gastric and colon cancer tissues].
    Chung SM; Kawai K; Chung HM; Kawamoto K; Tada M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Aug; 87(8):1678-85. PubMed ID: 2232301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteolytic enzymes in human lymphocytic leukemia cells. I. Activity of dipeptidylaminopeptidase IV, plasminogen activator and cathepsins B and L in cells with different immunologic phenotype].
    Lokshina LA; Bylinkina VS; Samoĭlova RS; Gureeva TA; Golubeva NV; Polianskaia AM
    Biokhimiia; 1993 Jul; 58(7):1104-15. PubMed ID: 8103371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
    van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
    Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells.
    Lesuffleur T; Barbat A; Dussaulx E; Zweibaum A
    Cancer Res; 1990 Oct; 50(19):6334-43. PubMed ID: 2205381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells.
    Cavallo-Medved D; Mai J; Dosescu J; Sameni M; Sloane BF
    J Cell Sci; 2005 Apr; 118(Pt 7):1493-503. PubMed ID: 15769846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
    Sohar N; Hammer H; Sohar I
    Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
    Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
    Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.
    Maynadier M; Farnoud R; Lamy PJ; Laurent-Matha V; Garcia M; Rochefort H
    Int J Oncol; 2013 Nov; 43(5):1683-90. PubMed ID: 24026424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation.
    Corticchiato O; Cajot JF; Abrahamson M; Chan SJ; Keppler D; Sordat B
    Int J Cancer; 1992 Oct; 52(4):645-52. PubMed ID: 1399147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
    Boyd D
    Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase activity in invasive cancer of the breast. Correlation with tumor progression.
    Benítez-Bribiesca L; Martínez G; Ruíz MT; Gutiérrez-Delgado F; Utrera D
    Arch Med Res; 1995; 26 Spec No():S163-8. PubMed ID: 8845643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state.
    Isidoro C; De Stefanis D; Démoz M; Ogier-Denis E; Codogno P; Baccino FM
    Cell Growth Differ; 1997 Sep; 8(9):1029-37. PubMed ID: 9300184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dipeptidyl aminopeptidase IV during enterocytic differentiation of human colon cancer (Caco-2) cells.
    Yoshioka M; Erickson RH; Matsumoto H; Gum E; Kim YS
    Int J Cancer; 1991 Apr; 47(6):916-21. PubMed ID: 1672667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human primary colon carcinomas xenografted into nude mice. II. Modulation of tumor plasminogen activator activity by the host tissue environment.
    Cajot JF; Sordat B; Bachmann F
    J Natl Cancer Inst; 1986 Nov; 77(5):1099-107. PubMed ID: 3095580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).
    Nauland U; Rijken DC
    Eur J Biochem; 1994 Jul; 223(2):497-501. PubMed ID: 8055919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells.
    Cavallo-Medved D; Dosescu J; Linebaugh BE; Sameni M; Rudy D; Sloane BF
    Neoplasia; 2003; 5(6):507-19. PubMed ID: 14965444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of the human colon carcinoma cell line HCT-8 to methotrexate results in selection of cells with features of enterocytic differentiation.
    Barbat A; Pandrea I; Cambier D; Zweibaum A; Lesuffleur T
    Int J Cancer; 1998 Mar; 75(5):731-7. PubMed ID: 9495241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.